NEW HAVEN, Conn.--CuraGen announced that its Board of Directors has approved a two-for-one stock split of the company’s common stock on March 30. At that time, stockholders will receive one additional share of the stock for every share each owned at the close of business on March 15. The stock will begin trading on a split-adjusted basis on March 31.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.